non-small cell lung cancer
Imagene, Tempus AI to Collaborate on AI-Based Lung Cancer Diagnostics
Imagene's AI-based multigene panel for predicting non-small cell lung cancer biomarkers from biopsy images will be combined with Tempus' real-world data.
TRACERx Lung Cancer Study Validates Prognostic Clonal Gene Expression Test
TRACERx researchers studied the 23-transcript ORACLE clonal expression biomarker, prospectively linking ORACLE risk classification to lung adenocarcinoma survival.
CellCarta, Biofidelity Partner to Offer Lung Cancer Assay for Clinical Trials
CellCarta will validate Biofidelity's Aspyre Lung assay in its European and US labs and will hold nonexclusive rights to use it in global clinical trials.
Volition Eyes East Asia Expansion With Nucleosome-Based Blood Test for Lung Cancer Screening
Premium
The firm hopes to include its lung cancer assay in Taiwan's national cancer screening program while developing sepsis and ovarian cancer assays.
Lung Cancer Study Reveals Tumor Microenvironment Role in Neoadjuvant Treatment Resistance
Researchers used single-cell and spatial transcriptomics to find immune cell interactions linked to neoadjuvant immunotherapy-chemotherapy response in non-small cell lung cancer.